Neocortical hyperexcitability after GABA withdrawal in vitro

Epilepsy Research

Volumn 39, Issue 1, 2000, Pages 13-26

  Calixto, E ^a   Lopez Colome A M ^a   Casasola, C ^a   Montiel, T ^a   Bargas, J ^a   Brailowsky, S ^a  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Epilepsy; GABA; GABA(A) receptor; Hyperexcitability; Neurosteroids; Withdrawal

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE; BICUCULLINE; DIAZEPAM; FLUNITRAZEPAM; MUSCIMOL; POSTSYNAPTIC RECEPTOR; PROGESTERONE; TRITIUM;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; EPILEPTIC DISCHARGE; EVOKED RESPONSE; GABAERGIC TRANSMISSION; NEOCORTEX; NERVE CELL EXCITABILITY; NONHUMAN; PERFUSION; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; SPIKE; SUPERFUSION; WITHDRAWAL SYNDROME;

ANIMALS; FLUNITRAZEPAM; GABA AGONISTS; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; MUSCIMOL; NEOCORTEX; PREGNANOLONE; PROGESTERONE; RATS; RATS, WISTAR; SEIZURES; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPTIC TRANSMISSION;

EID: 0343851116     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(99)00100-X     Document Type: Article

References (61)

1. Arias C., Montiel T., Tapia R. Transmitter release in hippocampal slices from rats with limbic seizures produced by systemic administration of kainic acid. Neurochem. Res. 15:1990;641-645.
2. Bauer J., Burr W., Elger C.E. Seizure occurrence during ovulatory and anovulatory cycles in patients with temporal lobe epilepsy: a prospective study. Eur. J. Neurol. 5:1998;83-88.
3. Baulieu E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52:1997;1-32.
4. Brailowsky S., Menini C., Silva-Barrat C., Naquet R. Epileptogenic gamma-aminobutyric acid withdrawal syndrome after chronic, intracortical infusion in baboons. Neurosci. Lett. 74:1987;75-80.
5. Brailowsky S., Kunimoto M., Menini C., Silva-Barrat C., Naquet R. The GABA-withdrawal syndrome: a new model of focal epileptogenesis. Brain Res. 442:1988;175-179.
6. Brailowsky S., Kunimoto M., Silva-Barrat C., Menini C., Naquet R. Electroencephalographic study of the GABA-withdrawal syndrome in rats. Epilepsia. 31:1990;369-377.
7. Brailowsky S., Montiel T. Isoguvacine supression induces long-lasting epileptogenic changes in the rat. Soc. Neurosci. Abstr. 17:1991;174.
8. Calixto E., Montiel T., Lemini C., Brailowsky S. Allopregnanolone potentiates a GABA-withdrawal syndrome in the rat cerebral cortex. Neurosci. Lett. 195:1995;73-76.
9. A/benzodiazepine receptor polypeptides from the surface of chick cortical neurons. J. Biol. Chem. 269:1994;1548-1553.
10. Cash D., Serfozo P., Allan A. Desensitization of a γ-aminobutiryc acid type A receptor in rat is increased by chronic treatment with chlordiazepoxide: a molecular mechanism of dependence. J. Pharmacol. Exp. Ther. 283:1997;704-711.
11. Creager R., Dunwiddie T., Lynch G. Paired pulse and frequency facilitation in the CA1 region of the in vitro rat hippocampus. J. Physiol. 299:1980;409-424. , London.
12. Davies C., Davies S., Collinridge G. Paired pulse depression on monosynaptic GABA mediated inhibitory postsynaptic response in the rat hippocampus. J. Physiol. 424:1990;513-531. , London.
13. A /benzodiazepine receptor as a target for psychoactive drugs. Neuroscience Intelligence Unit. 1996;Chapman and Hall, New York.
14. Ffrench-Mullen J., Danks P., Spence K. Neurosteroids modulate calcium currents in hippocampal CA1 neurons via pertussis toxin G-protein-coupled mechanism. J. Neurosci. 14:1994;1963-1977.
15. Finn D., Roberts A., Crabbe J. Neuroactive steroid sensitivity in withdrawal seizure-prone and resistant mice. Alcohol Clin. Exp. Res. 19:1995;410-415.
16. Frances D., Sasaki S., Carlen P. Benzodiazepine-induced epileptiform activity in vitro. Brain Res. 437:1987;237-244.
17. Frances D., Sasaki S., Carlen P. Hiperexcitability of hippocampal CA1 neurons in brain slices of rats chronically administered clonazepam. J. Exp. Pharmacol. Exp. Ther. 247:1988;737-744.
18. Fricke V. A new scintillation cocktail based on Triton-X-100. Anal. Biochem. 63:1975;555-558.
19. Frosch M., Lipton S., Dichter M. Desensitization of GABA-activated currents and channel in cultured cortical neurons. J. Neurosci. 12:1992;3042-3053.
20. Frye C. The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696:1995;113-120.
21. García-Ugalde G., Galarraga E., Bargas J., Brailowsky S. Hyperexcitability of hippocampal CA1 region in brain slices after GABA withdrawal. Neurosci. Lett. 147:1992;229-232.
22. A receptors. Biochem. Biophys. Res. Com. 219:1996;531-536.
23. Herkes G.K., Eadie M.J., Sharbrough F., Moyer T. Patterns of seizure occurrence in catamenial epilepsy. Epilepsy Res. 15:1993;47-52.
24. Herzog A.G. Reproductive endocrine considerations and hormonal therapy for women with epilepsy. Epilepsia. 32:1991;S27-S33.
25. Higgins M., Stone T. Bicuculline-resistant paired pulse inhibition in the rat hippocampal slice. Br. J. Pharmacol. 109:1993;1164-1168.
26. Hu X., Ticku M. Chronic benzodiazepine agonist treatment produces functional uncoupling of the GABA/benzodiazepine receptor ionophore complex in cortical neurons. Mol. Pharmacol. 45:1994;618-625.
27. Hu X., Ticku M. Chronic flurazepam treatment produces decreased efficacy of the benzodiazepine ligands and pentobarbital with γ-aminobutyric acid A receptor subtypes. J. Pharmacol. Exp. Ther. 266:1994;385-391.
28. Krishek B., Xie X., Blackstore E. Regulation of GABAA receptor function by protein Kinase C phosphorylation. Neuron. 12:1994;1081-1095.
29. Krnjevic' K. Role of GABA in the cerebral cortex. Can. J. Physiol. Pharmacol. 75:1997;439-451.
30. Kublí-Garfias C. Physiological role of 5α and 5β-progesterone metabolites on the CNS. TIPS. 5:1984;439-444.
31. A receptors. Cell. Mol. Neurobiol. 16:1996;155-174.
32. Landren S.O. Pregnenolone (3α-hidroxy-5α-pregnan-20-one), a progesterone metabolite, facilitates inhibition of synaptic transmission in the Schaffer collateral pathway of the guinea pig hippocampus in vitro. Epilepsy Res. 10:1991;156-165.
33. Le Gal La Salle G., Brailowsky S., Menini C., Naquet R. Local asymptomatic status epilepticus induced by withdrawal of GABA infusion into limbic structures. Exp. Neurol. 101:1988;411-417.
34. 3H]muscimol binding to brain synaptic membranes by progesterone and related pregnanes. Eur. J. Pharmacol. 176:1990;297-303.
35. +-stimulated release of labeled γ-aminobutyrate, glicine and taurine in slices of several regions of rat cerebral nervous system. Neuroscience. 3:1978;1069-1074.
36. Lowry O.H., Rosenbrough N., Farr A., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
37. Meldrum B. Neurotransmission in Epilepsy. Epilepsia Suppl. 36:1995;S30-S35.
38. Monimoto K., Sato K., Sato S., Yamada N., Hayabara T. Time dependent changes in neurotrophic factor mRNA expression after kindling and long term potentiation in rats. Brain Res. Bull. 45:1998;599-605.
39. Moran M.H., Smith S.S. Progesterone withdrawal I: pro-convulsant effects. Brain Res. 807:1998;84-90.
40. Newmark M.E., Penry J.K. Catamenial epilepsy: a review. Epilepsia. 21:1980;281-300.
41. A receptor binding in human brain by neuroactive steroids: species and brain regional differences. Synapse. 19:1995;77-87.
42. Olsen R., Avoli M. GABA and epileptogenesis. Epilepsia. 38:1997;399-407.
43. A receptors. Adv. Biochem. Psychopharmacol. 47:1992;103-110.
44. A receptor subunit expression in rat neocortical areas. Neurosci. 79:1997;477-487.
45. Reddy D., Kulkarni S. Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity. Exp. Clin. Pharmacol. 19:1997;395-405.
46. Ryan G., Boise N. Benzodizepine tolerance, physical dependence and withdrawal: electrophysiological study of spinal reflex function. J. Pharmacol. Exp. Ther. 231:1984;464-471.
47. Salazar P., Montiel T., Brailowsky S., Tapia R. Decrease of glutamate decarboxilase activity after in vivo cortical infusion of γ-aminobutyric acid. Neurochem. Int. 24:1994;363-368.
48. Schwartz J., Elikplimi A., Mealing G., Tsang B., Rousseau E., Whitfield J., Payet M. T- and L-calcium channels in steroid-producing chicken granulosa cell in primary culture. Endocrinology. 125:1989;1973-1982.
49. Silva-Barrat C., Araneda S., Menini C., Champagnat J., Naquet R. Burst generation in neocortical neurons after GABA withdrawal in the rat. J. Neurophysiol. 67:1992;715-727.
50. Silva-Barrat C., Champagnat J., Brailowsky S., Menini C., Naquet R. Tolerance to GABAA agonist may explain bursting properties of neocortical neurons during GABA withdrawal syndrome. Brain Res. 498:1989;289-298.
51. Spindler K. Interaction between steroid hormones and the nervous system. Neurotoxicology. 18:1997;745-754.
52. Speark G., Scharzer C., Tsunashian R., Kandlofer S. Expression of GABAA receptor subunits in the hippocampus of the rat after kaninc acid-induced seizures. Epilepsy Res. 32:1998;129-139.
53. Steffensen S., Henrikesen S. Effects of baclofen and bicuculline on inhibition in the fascia dentata and hippocampus region superior. Brain Res. 538:1991;46-53.
54. Tehrani J.M.H., Barnes E. GABA down-regulation the GABA/benzodiazepine receptor complex in developing cerebral neurons. Neurosci. Lett. 87:1988;288-292.
55. Traub R.D., Jefferys J.G.R. Are there unifying principles underlying the generation of epileptic after discharges in vitro? Prog. Brain. Res. 102:1994;383-394.
56. Tukey J.W. Exploratory Data Analysis. 1977;Addison-Wesley, Menlo Park, CA.
57. Wang J., Ko -G., Kelly P. Cellular and molecular bases of memory: synaptic and neuronal plasticity. J. Clin. Neurophysiol. 14:1997;264-293.
58. Wheling M. Specific, nongenomic actions of steroid hormones. Ann. Rev. Physiology. 59:1997;365-393.
59. Yu R., Ticku M. Chronic neurosteroid treatment decrease the efficacy of benzodiazepine ligands and neurosteroids at the gamma aminobutyric acid A receptor complex in mammalian cortical neurons. J. Pharmacol. Exp. Ther. 275:1995;784-789.
60. A receptor complex in mammalian cortical neurons. J. Pharmacol. Exp. Ther. 275:1995;1442-1446.
61. A channel deactivation by altering kinetics of desensitized states. J. Neurosci. 17:1997;4022-4031.